2014 Press Releases

AACC Encourages Congress to Finalize Healthcare Bill That Will Prevent Disability and Death Caused by Childhood Genetic Disorders
WASHINGTON – Clinical laboratory testing ensures that thousands of infants receive life-saving treatments every year, yet certain pediatric testing programs could lose their funding if Congress does not finalize the Newborn Screening Saves Lives Reauthorization Act of 2013. On October 14, AACC will host a congressional briefing to discuss how this legislation could save even more children from death and disability by enabling advances in pediatric laboratory testing to continue.

AACC Elects Clinical Director at Children's Medical Center in Dallas as 2016 President
WASHINGTON – AACC is pleased to announce that Patricia M. Jones, PhD, DABCC, FACB, has been elected to serve on the AACC Board as president-elect beginning in January 2015, followed by successive terms as the association's 67th president in 2016 and past president in 2017. The AACC membership also elected two new members to the association's Board of Directors and two new members to the Nominating Committee who will take office at the start of next year.

CDC Official to Advise Labs on Testing Patients for Ebola Now That First Case of Deadly Virus Has Been Confirmed in the U.S.
WASHINGTON – Now that the Ebola virus has arrived in the U.S., the ability of clinical laboratories to quickly identify patients who need treatment and require isolation will play a critical role in preventing an outbreak. To help labs prepare for this, AACC will host a webinar on October 7 featuring Nancy E. Cornish, MD, a medical officer with the Centers for Disease Control and Prevention's Division of Laboratory Science and Standards.

FDA Director for Diagnostic Tests to Discuss the Agency's Proposed Framework to Oversee Laboratory Developed Tests
WASHINGTON – On September 10, AACC will host a webinar with Alberto Gutierrez, PhD, director of the Office of In Vitro Diagnostics and Radiological Health in the Food and Drug Administration's (FDA's) Center for Devices and Radiological Health to explain the agency's long-awaited proposal for oversight of laboratory developed tests (LDTs). LDTs play an integral role in diagnosing a wide range of medical conditions, including congenital disorders, infectious diseases, drug abuse, and cancer.

Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo
CHICAGO – Nearly 20,000 medical professionals and healthcare leaders gathered for AACC's 65th Annual Meeting & Clinical Lab Expo in Chicago from July 27–31. The meeting featured never-before-seen breakthroughs in diagnostic research and technology that will advance medicine and get patients the treatment they need.

First-Ever AACC Virtual Conference to Focus on Personalized Diagnostics
CHICAGO – One of the major revolutions taking place in healthcare is the rise of personalized medicine, which is the practice of using genomic and other molecular analyses to tailor medical treatments to a patient's individual biology. Personalized diagnostics—laboratory analyses that inform the practice of personalized medicine—will play a major role in the lab's future. This fall, AACC's first ever virtual conference will feature the latest science in this exciting field and the novel technologies driving it forward, all in a convenient format that people can access without leaving their offices or homes. 

Lab-on-a-Chip Technology to Be Featured at 2014 AACC Annual Meeting & Clinical Lab Expo
CHICAGO – As one of the 10 largest medical exhibitions in the U.S., the 2014 AACC Annual Meeting & Clinical Lab Expo is the place where breakthrough innovations in clinical testing and patient care are introduced to the healthcare world. This year, many of the trailblazing products displayed by the Expo's 650 exhibitors will include the latest diagnostic technology in the field of mobile health.

AACC Announces 2014 Corporate Supporter Award Winners; Thanks Organizations for Their Invaluable Support
CHICAGO – AACC is pleased to announce the recipients of the AACC 2014 Corporate Supporter Awards. Each year, AACC recognizes the companies and organizations that generously support the association through sponsorships, advertising, and exhibiting. These significant contributions make it possible for AACC to improve patient care by fostering research, innovation, and professional excellence in the field of laboratory medicine.

Major Advances in Alzheimer's, Colon Cancer, Multiple Myeloma, and Sleep Apnea Testing, and in Maternal-Fetal Health Research to Be Highlighted at 2014 AACC Annual Meeting
CHICAGO – The groundbreaking scientific studies featured at the 2014 AACC Annual Meeting & Clinical Lab Expo will include research on a blood test for Alzheimer's that uses biochip technology, a new test to diagnose colon cancer early, a more accurate method for determining multiple myeloma prognosis, a less stressful test for sleep apnea, and the development of a bank of biospecimens from pregnant women that could prove crucial for women's health research.

Mobile Health, Big Data, and Antimicrobial Resistance Take Center Stage at the 2014 AACC Annual Meeting & Clinical Lab Expo
CHICAGO – At the world's largest conference and exhibit for laboratory medicine, AACC will showcase the cutting edge science and technology shaping the future of medical testing and patient care. This year, the meeting will include the latest news about mobile health, big data, and infectious disease testing, among many other major healthcare topics.

AACC Debuts Refreshed Brand Identity
CHICAGO – AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, unveiled an updated brand identity today that reflects the organization's commitment to help laboratory professionals adapt to the changing healthcare environment and continue to do what they do best: provide vital insight to physicians, so patients get the care they need.

AACC Supports Expansion of Medical Program That Saves 12,500 Infant Lives Each Year
WASHINGTON – On July 11th, AACC released a position statement on newborn screening, the practice of testing every newborn for medical conditions that cause disabilities, developmental delays, or death.

AACC Urges New York State to Rescind Policy Directive That Could Negatively Impact Patients by Restricting the Use of Blood Glucose Meters
WASHINGTON – On January 13, the New York State (NYS) Department of Health issued a directive limiting the ways in which NYS medical laboratories can use blood glucose meters to help patients. Although AACC shares the Department's desire to ensure that blood glucose devices are used safely and appropriately, the association is concerned that this policy may impede the delivery of quality patient care and advises the Department to rescind it.

Early Alzheimer's Blood Test Co-Developer to Discuss How the Test Could Be the First Step in Developing Treatments to Halt or Slow Alzheimer's at 2014 AACC Annual Meeting
WASHINGTON In March of this year, a team of Georgetown University scientists published research showing that, for the first time ever, a blood test has the potential to predict Alzheimer's disease before patients start showing symptoms. AACC is pleased to announce that a late-breaking session at the 2014 AACC Annual Meeting & Clinical Lab Expo in Chicago will expand upon this groundbreaking research and discuss why it could be the key to curing this devastating illness.

AACC Supports FDA Effort to Improve Blood Glucose Meters but Believes the New Standards Could Encumber the Use of These Monitors Without Benefiting Patients
WASHINGTON In January, the U.S. Food and Drug Administration (FDA) released draft guidance proposing separate performance and accuracy criteria for over-the-counter blood glucose meters used in the home and prescription blood glucose meters used in hospitals. AACC supports FDA's initiative to improve the quality of these devices and enhance patient care, but recommends revising this draft guidance to ensure that it does not unnecessarily increase the regulatory burden and costs on the healthcare system.

AACC to Examine Controversial New Law That Could Mean $2.5 Billion in Cuts to Medical Testing Over the Next 10 Years
WASHINGTON – On May 7, AACC will host a webinar about the Protecting Access to Medicare Act of 2014, a new law signed by the president on April 1 that will make the most significant changes to medical test reimbursement that clinical laboratories have seen in 3 decades.

Is FDA's Crackdown on Direct-to-Consumer Genetic Testing a Violation of the First Amendment?
WASHINGTON – In November 2013, the U.S. Food and Drug Administration (FDA) ordered the company 23andMe to stop offering its direct-to-consumer DNA testing service, which provided individuals with $99 assessments of their genetic risk for almost 200 disorders. A thought-stimulating opinion piece published in Clinical Chemistry, the journal of AACC, now examines whether this move by FDA is a violation of the First Amendment, or a necessary step to protect consumers. 

Most Hospital Pregnancy Tests Found to Be Unreliable After First Few Weeks of Pregnancy
WASHINGTON – Though the 11 most popular hospital urine pregnancy tests perform well in the first month after conception, a new study published in Clinical Chemistry, the journal of AACC, reveals the alarming statistic that nine of these tests become significantly more likely to produce false-negative results after the 5th to 7th week of pregnancy.

FDA Division Director to Discuss Proposed Regulations That Aim to Improve Diabetes Patient Care
WASHINGTON – March 18, 2014 - On March 19, AACC will host a webinar with FDA division director Courtney Lias, PhD, about FDA's new draft guidance proposing separate performance and accuracy criteria for over-the-counter blood glucose meters used in the home and prescription point-of-care blood glucose meters used in the hospital.

New Discoveries by Scientific Working Group Could Advance Ability to Detect HGH Doping in Sport
WASHINGTON – March 12, 2014 - Anti-doping experts continue to advance the science of future testing methods, building on the existing tests for growth hormone (GH) abuse in sport that have been successful in detecting dopers. Now, breaking research appearing in Clinical Chemistry, the journal of the American Association of Clinical Chemistry, shows that measuring IGF-1 as a biomarker of GH activity – through a chemistry technique known as liquid chromatography-tandem mass spectrometry (LC-MS/MS) – could increase the detection of and prevent GH doping by greatly enhancing inter-laboratory precision.

President's Budget Proposal Could Decrease Access to Lab Tests Vital to Patient Care
WASHINGTON – March 5, 2014 - The following statement is attributable to AACC CEO Janet B. Kreizman: "Healthcare professionals routinely use laboratory tests to diagnose, treat, and monitor health conditions ranging from high cholesterol and diabetes to cardiac disease and AIDS. The President's FY 2015 budget proposal, if implemented, could adversely affect patient access to these vital services while reducing the overall quality of testing."

FDA Director to Address the Final Guidance on Research and Investigational Use Only Devices
WASHINGTON – February 25, 2014 - AACC will host a webinar with Alberto Gutierrez, PhD, director of the Office of In Vitro Diagnostics in the Center for Devices and Radiological Health at FDA to discuss FDA's guidance on in vitro diagnostic products labeled for research use only (RUO) or investigational use only (IUO).

AACC Announces 2014 Award Winners; Celebrates Achievements in Laboratory Medicine
WASHINGTON – February 21, 2014 - AACC is pleased to announce the recipients of the 2014 AACC Awards. Each year, AACC recognizes individuals from around the world for their superior contributions to the field of laboratory medicine with its awards program, which aims to encourage excellence within the profession and raise awareness about the importance of clinical laboratory science to improving healthcare.

AACC Supports HHS Decision to Strengthen Patients' Right to Access Lab Reports; Consultation with Physicians Remains Essential
WASHINGTON – February 3, 2014 - Today, the U.S. Department of Health and Human Services (HHS) announced a ruling that allows patients direct access to their completed test reports. AACC supports this new ruling and applauds the ongoing efforts of HHS to empower patients to be informed healthcare consumers.

AACC Supports Reauthorization of Newborn Screening Act; Works to Improve Treatment of Childhood Diseases by Identifying Ranges of Healthy Development
WASHINGTON – January 30, 2014 - On January 29, the U.S. Senate passed the Newborn Screening Saves Lives Reauthorization Act of 2013 (S.1417) by unanimous consent. Introduced by Senators Kay Hagan (D-N.C.) and Orrin Hatch (R-Utah), this bipartisan bill reauthorizes funding for various newborn-screening programs for the next five years. AACC applauds the Senate's approval of this legislation, which is integral to improving children's health, and urges the U.S. House of Representatives to pass it as well.

What Is Different About Women's Health?
WASHINGTON – January 6, 2014 - Until recently, a large percentage of medical knowledge came from studies of predominantly male populations, but slowly, the scientific community has realized the need for research focusing specifically on women. The new special "Advancing Women's Health" issue of Clinical Chemistry, the journal of AACC, showcases nearly 50 studies that close the gap between men's and women's healthcare by shedding light on how heart disease, cancer, reproductive problems, and other common health issues manifest differently in women than in men at the molecular and genetic level.

Designing Genes Through Diagnosis
WASHINGTON – January 6, 2014 - Jodi Picoult's 2004 novel My Sister's Keeper became a bestseller by exploring the fate of a young girl who is genetically engineered to be a donor match for her cancer-stricken older sister. My Sister's Keeper is fiction, but it is based on the reality of preimplantation genetic diagnosis (PGD). A new Q&A in the "Advancing Women's Health" issue of Clinical Chemistry, the journal of AACC, explores the ethics of PGD, a form of genetic testing that has already made it possible for parents to conceive a child who is a donor match for a sick relative, who shares their minor disability (such as deafness), or to select gender.

Promising New Biomarkers Linked to Early Diagnosis of Breast Cancer
WASHINGTON – January 6, 2014 - Two new papers in the "Advancing Women's Health" issue of Clinical Chemistry, the journal of AACC, show for the first time that measuring the amount of certain protein fragments and microRNAs in a woman's blood and breast tissue might enable the early diagnosis of breast cancer or prediction of its metastasis, respectively.

Underdiagnosis of Women's Heart Disease Not Resolved by Sex-Specific Criteria
WASHINGTON – January 6, 2014 - The symptoms of heart disease are often less obvious in women than in men, and as a result, some experts have recommended changing current medical practice and using separate criteria to identify the disease and predict its progression in women. However, new findings in the "Advancing Women's Health" issue of Clinical Chemistry, the journal of AACC, suggest that sex-specific criteria do not improve the prognostic accuracy of blood tests for diagnosing heart disease.


2013 Press Releases

AACC Calls for Uniformity in Lab Test Results
WASHINGTON – November 22, 2013 - AACC has released a position statement on harmonization of—or ensuring uniformity among—clinical laboratory test results to help patients receive appropriate diagnoses and medical treatment. With this statement, the association aims to raise awareness about this essential healthcare issue and urge the medical community to work together to make harmonization a reality.

AACC Annual Meeting and Clinical Lab Expo Named the Fastest Growing Trade Show by Trade Show News Network
WASHINGTON – November 4, 2013 - AACC is pleased to announce that the AACC Annual Meeting & Clinical Lab Expo won the 2013 Trade Show News Network (TSNN) award for having the fastest growing attendance of all nonprofit trade shows. The AACC Annual Meeting is also known for being the world's largest diagnostics conference and expo.

AACC Unveils Online Tool to Help Students Prepare for Clinical Board Exams
WASHINGTON – October 14, 2013 - AACC is pleased to announce the launch of the Question Bank, an innovative online tool that will make it significantly easier for laboratory medicine trainees to prepare for U.S. and U.K. board examinations.

AACC Elects New Leaders to Serve in 2014
WASHINGTON – October 7, 2013 - AACC is pleased to announce that four new members have been elected to the association's Board of Directors and will begin serving in January 2014. The AACC membership also elected two new members to the Nominating Committee, which is responsible for choosing future candidates for both the Nominating Committee and the AACC Board.

Unreliable Commercial Lab Kits May Be Hindering the Fight Against Cancer
WASHINGTON October 4, 2013 - Over the past 30 years, researchers have developed surprisingly few new tests for diagnosing cancer in spite of impressive advances in biomedical technology. A study appearing online today in Clinical Chemistry, the journal of AACC, shows for the first time that low quality commercial lab kits may be one factor hampering the progress of cancer diagnostics.

Thousands Come For Cutting Edge Science and Technology at the 2013 AACC Annual Meeting and Clinical Lab Expo
Houston – AACC welcomed more than 17,500 medical professionals to the association's 63rd Annual Meeting and Clinical Lab Expo from July 28–August 1.

AACC Pilot Studies Begin to Measure What Is Normal in Children's Development
Houston—AACC's Pediatric Reference Range Committee (PRRC) is performing two pilot studies to establish crucial pediatric reference intervals as part of the National Children's Study. Researchers speaking at AACC's 2013 Annual Meeting will discuss preliminary findings from these studies and underscore their importance to improving pediatric healthcare.

AACC's New Online Tool Could Revolutionize How Students Prepare for Clinical Board Examinations
Houston – AACC is pleased to announce an exclusive sneak preview of its new Question Bank at the 2013 AACC Annual Meeting & Clinical Lab Expo in Houston. Created to help laboratory medicine trainees prepare for board examinations in the U.S. and U.K., the Question Bank is the most extensive compilation of board study questions ever collected.

Lab Tests Online Hosts Its 150 Millionth Visitor, Continues to Expand Global Presence
Houston – Lab Tests Online, the world's leading website for patient health literacy on laboratory testing, is pleased to announce that it has reached a major milestone—serving its 150 millionth visitor.  

AACC Hires Cunningham Associates as Lead Advertising Agency
WASHINGTON July 25, 2013 - AACC today announced that it has awarded its advertising business to Cunningham Associates, effective October 1.

AACC Annual Meeting Breaking Science Includes New Tests to Detect Life-Threatening Prostate Cancer, New Cystic Fibrosis Tests That Can Be Measured at the Point of Care, and New Ways to Determine the Safety of Drugs Used to Treat Schizophrenia and Bipolar Disorder
WASHINGTON July 18, 2013 - Leaders from the medical diagnostics, laboratory medicine, and health care fields will convene in Houston, Texas, July 28 – August 1 for the world's largest diagnostics conference and expo where experts from research and industry will exchange insights on research and application advancements. More than 17,000 attendees and an exhibit with more than 625 companies are expected. Selected research being presented includes new tests to detect life-threatening prostate cancer, new cystic fibrosis tests that can be measured at the point of care, and new ways to determine the safety of drugs used to treat schizophrenia and bipolar disorder.

AACC Annual Meeting Late-Breaking Session on Supreme Court Gene Patent Ruling Features ACLU Lead Counsel Sandra Park
WASHINGTON AACC is pleased to announce the addition of a late-breaking session, The Supreme Court Decision on Human Gene Patents and Its Implications, to its scientific program at the 2013 AACC Annual Meeting & Clinical Lab Expo in Houston.

New Test for H7N9 Bird Flu in China May Help Slow Outbreak, Prevent Pandemic
WASHINGTON Breaking research appearing online today in Clinical Chemistry, the journal of AACC, demonstrates that a recently developed diagnostic test can detect the new strain of influenza (H7N9) currently causing an outbreak in China.

For Smokers, Low Levels of Vitamin D May Lead to Cancer
WASHINGTON - New research appearing online today in Clinical Chemistry, the journal of AACC, shows that decreased levels of vitamin D may predispose smokers to developing tobacco-related cancer. This study illustrates that simple vitamin D blood tests and supplements have the potential to improve smokers' health.

New Study Shows Cannabis Effects on Driving Skills
WASHINGTON - New research appearing online today in Clinical Chemistry, the journal of AACC, shows that cannabis can be detected in the blood of daily smokers for a month after last intake. The scientific data in this paper by Bergamaschi et al. can provide real help in the public safety need for a drugged driving policy that reduces the number of drugged driving accidents on the road.

Janet Kreizman Appointed Chief Executive Officer of AACC
WASHINGTON - The Board of Directors of the American Association for Clinical Chemistry (AACC) today announced that it has appointed Janet B. Kreizman Chief Executive Officer effective April 1, 2013.

AACC Announces 2013 Award Winners
Washington, DC, February 8 - The American Association for Clinical Chemistry (AACC) is pleased to announce the recipients of its 2013 awards. The 2013 AACC Award winners will be recognized during the AACC Annual Meeting and Clinical Lab Expo at the Opening Plenary Session on Sunday, July 28, in Houston, Texas. AACC is proud to celebrate noteworthy contributions to the field of laboratory medicine worldwide through this awards program and congratulates this year's winners.

Special Issue of Clinical Chemistry Provides Update on Fight Against Cancer, Shows Promising Trends in Personalized Treatment for Patients
Washington, DC, January 23 - Clinical Chemistry, the journal of AACC, has published a special issue devoted to the subject of cancer. With cancer surpassing cardiovascular disease as the number one killer in the Western world, the issue provides a cutting edge update on the state of cancer research in laboratory medicine today. The issue includes nearly 50 articles covering a wide range of topics, including companion diagnostics, the modeling of cancer initiation and progression, novel cancer therapies such as chemoprevention and targeting the tumor microenvironment, and the potential of genomics and metabolomics to improve personalized cancer management.

Breakthrough Research Could Create Sea Change in Global HIV Diagnosis: New Handheld Mobile Device Performs Laboratory-Quality HIV Testing
Washington, DC, January 18 - New research appearing online today in Clinical Chemistry, the journal of AACC, shows that a handheld mobile device can check patients' HIV status with just a finger prick, and synchronize the results in real time with electronic health records. This technology takes a step toward providing remote areas of the world with diagnostic services traditionally available only in centralized healthcare settings.

Breakthrough Research in DNA Mutation Analysis Could Lead to Earlier Diagnosis and More Tools for Personalized Treatment for Cancer Patients
Washington, DC, January 2 - New research appearing online today in Clinical Chemistry, the journal of AACC, shows that the analysis of DNA mutations in patients with cancer can be done without surgery. This paper by Chan et al. shows that the plasma of cancer patients also carries tumor-derived DNA. Because the DNA sequencing of plasma is non-invasive, this could lead to cheap and highly informative clinical tools for early cancer diagnosis and personalized therapy selection, granting better health outcomes to all cancer patients.​​​​​​​

 

​ ​

Page Access:

AACC_CCJ_ad